2Feleszko W,Zagozdzon R,Golab J,et al.Potentiated antitumor effects of cisplatin and lovastatin against MmB16 melanoma in mice[J].Eur Cancer,1998,34(3):406-411.
3Mater P,Rozados VR,Roggero EA,et al.Lovastatin inhibits tumor growth and metastasis development of a rat fibro sarcoma[J].Cancer Biother Radiopharm,1998,13(5):387-393.
4Li HY,Appelbaum FR,Willman CL,et al.Cholesterd -modulating agents kill acute myeloid leukemia cells and sensitize them to therpentics by blocking adaptive cholesterd responses[J].Blood,2003,101(9):3628-3634.
5Mueck AOSeeger H,Wallwiener D.Effect of statins combined with estraiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells[J].Menopause,2003,10(4):332-336.
6Pedersen TR,Wlikemsen O,et al.Follow-up study of patients randomized in the Scandinavian simvastatin survival study(4S)of cholesterol lowering[J].Am J Cardiol,2000,86(3):257-262.
7Jenny N,Poynter,M P H,Stephen B,et al.Statins and the risk of the colorectal cancer[J].The New England Journal of Medicine,2005,352:2184-92.
8Keyomarsi K,Sandoval L,Band V,and Pardee,A B.Synchronization of tumor and normal cells from G1 to multiple cell cycles by Lovastatin[J].Cancer Res,1991,51:3602-3609.
9Martinez BJ,Ferruel AJ,Suarez Y,et al.Dose-dependent effects of lovastatin on cell cycle progression;distinct requirement of cholesterol and non-sterol mevalonate derivatives[J].Biochim Biophys Acta,2001,1532(3):185-194.
1Solomon SD, MCMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med, 2005, 352(11) :1071-1080.
2Senior K. COX-2 inhibitors: cancer prevention or cardiovascular risk?Lancet Oncol, 2005, 6(2):68.
3Sleijfer S, Planting AS, Stoter G, et al. The potential of statins as part of anti-cancer treatment. Eur J Cancer, 2005, 41(4) :516-522.
4Graaf MR, Richel DJ, van Noorden CJ, et al. Effects of statins and farne-syltransferase inhibitors on the development and progression of cancer. Cancer Treat Rev, 2004, 30(7) :609-641.
5Xia Z, Tan MM, Wong WW, et al. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia, 2001, 15(9):1398-1407.
6Denoyelle C, Albanese P, Uzan G, et al. Molecular mechanism of the anticancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. Cell Signal, 2003, 15(3) :327-338.
7Abdelrahim M, Safe S. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol, 2005, 68(2) :317-329.
8Fu YG, Sung JJ, Wu KC, et al. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants. Cancer Lett, 2005, 224(2) :243-252.
